Transcatheter Edge-to-Edge Mitral Valve Repair versus Minimally Invasive Mitral Valve Surgery: An Observational Study
- PMID: 38592259
- PMCID: PMC10932335
- DOI: 10.3390/jcm13051372
Transcatheter Edge-to-Edge Mitral Valve Repair versus Minimally Invasive Mitral Valve Surgery: An Observational Study
Abstract
Background: Minimally invasive mitral valve surgery (MIC-MVS) has been established as preferred treatment of mitral regurgitation (MR), but mitral transcatheter edge-to-edge valve repair (M-TEER) is routinely performed in patients at high surgical risk and is increasingly performed in intermediate risk patients. Methods: From 2010 to 2021, we performed 723 M-TEER and 123 isolated MIC-MVS procedures. We applied a sensitivity analysis by matching age, left ventricular ejection fraction (LVEF), EuroSCORE II and etiology of MR. Results: Baseline characteristics showed significant differences in the overall cohort (p < 0.01): age 78.3 years vs. 61.5 years, EuroSCORE II 5.5% vs. 1.3% and LVEF 48.4% vs. 60.4% in M-TEER vs. MIC-MVS patients. Grade of MR at discharge was moderate/severe in 24.5% (171/697) in M-TEER vs. 6.5% (8/123) in MIC-MVS (p < 0.01). One-year survival was 91.5% (552/723) in M-TEER vs. 97.6% (95/123) in MIC-MVS (p = 0.04). A matching with 49 pairs (n = 98) showed comparable survival during follow-up, but a numerically higher mean mitral valve gradient of 4.1 mmHg (95% CI: 3.6-4.6) vs. 3.4 mmHg (95% CI: 3.0-3.8) in M-TEER (p = 0.04). Conclusions: Patients undergoing M-TEER had lower one-year survival than MIC-MVS, but differences disappeared after matching. Reduction in MR was less effective in M-TEER patients and postprocedural mitral valve gradients were higher.
Keywords: edge-to-edge repair; innovations; microinvasive cardiac surgery; minimally invasive cardiac surgery; mitral regurgitation; mitral valve surgery.
Conflict of interest statement
Miriam Silaschi has received research grants from Medtronic, LSI solutions and Cryolife Inc. and travel c ompensation from Edwards Lifesciences Inc. and is an advisory board member for JenaValve Technologies. Atsushi Sugiura has received honoraria for lectures from Edwards Lifesciences. Tetsu Tanaka has been financially supported in part by a Fellowship from the Japanese College of Cardiology and the Uehara Memorial Foundation. Georg Nickenig and Sebastian Zimmer have received research funding from the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research, the EU, Abbott, Edwards Lifesciences and Medtronic and have received honoraria for lectures or advisory boards from Abbott, Edwards Lifesciences and Medtronic. Marcel Weber has received lecture or proctoring fees from Abbott and Edwards Lifesciences. The other authors have no conflicts of interest.
Figures



Similar articles
-
Minimally Invasive Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair.Innovations (Phila). 2022 Jan-Feb;17(1):42-49. doi: 10.1177/15569845211070568. Innovations (Phila). 2022. PMID: 35225065
-
Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair: From the CUTTING-EDGE Registry.JACC Cardiovasc Interv. 2023 May 22;16(10):1176-1188. doi: 10.1016/j.jcin.2023.02.029. JACC Cardiovasc Interv. 2023. PMID: 37225288
-
Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.Eur Heart J. 2022 May 1;43(17):1626-1635. doi: 10.1093/eurheartj/ehab910. Eur Heart J. 2022. PMID: 35090000
-
Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.Catheter Cardiovasc Interv. 2024 Feb;103(2):340-347. doi: 10.1002/ccd.30944. Epub 2023 Dec 29. Catheter Cardiovasc Interv. 2024. PMID: 38156508
-
Clinical Impact of Tricuspid Regurgitation on Transcatheter Edge-to-Edge Mitral Valve Repair for Mitral Regurgitation.Cardiovasc Revasc Med. 2022 Aug;41:1-9. doi: 10.1016/j.carrev.2022.01.027. Epub 2022 Feb 5. Cardiovasc Revasc Med. 2022. PMID: 35398010
References
-
- Goldstone A.B., Atluri P., Szeto W.Y., Trubelja A., Howard J.L., MacArthur J.W., Jr., Newcomb C., Donnelly J.P., Kobrin D.M., Sheridan M.A., et al. Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: A propensity-matched comparison. J. Thorac. Cardiovasc. Surg. 2013;145:748–756. doi: 10.1016/j.jtcvs.2012.09.093. - DOI - PMC - PubMed
-
- Cheng D.C., Martin J., Lal A., Diegeler A., Folliguet T.A., Nifong L.W., Perier P., Raanani E., Smith J.M., Seeburger J., et al. Minimally invasive versus conventional open mitral valve surgery: A meta-analysis and systematic review. Innovations. 2011;6:84–103. - PubMed
-
- Falk V., Cheng D.C., Martin J., Diegeler A., Folliguet T.A., Nifong L.W., Perier P., Raanani E., Smith J.M., Seeburger J. Minimally invasive versus open mitral valve surgery: A consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010. Innovations. 2011;6:66–76. - PubMed
LinkOut - more resources
Full Text Sources